Used as a pharmaceutical intermediate, it is an important intermediate of the new antipyretic analgesic - tapentadol. The drug is mainly used to relieve moderate and severe acute pain, especially for the relief of adults over 18 years of age. Its quick release tablets were approved by the US Food and Drug Administration (trade name: NUCNTA) in November 2008 to relieve moderate and severe acute pain;Its sustained-release tablets were approved for marketing in August 2012 (trade name: NUCYNTA ER) for the treatment of adult diabetic neuropathy (DPN) -related neuropathic pain.In addition, it also can participate in a variety of organic synthesis.
Store in a cool, dry place, avoid direct sunlight. Store in a tightly closed container.
200kgs/iron drum with plastic lining
Exposure Controls, Personal Protection
Engineering Controls: Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Personal Protective Equipment
Eyes: Wear safety glasses and chemical goggles if splashing is possible.
Skin: Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing: Not available.
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
The toxicological properties of this material have not been investigated. Use appropriate procedures to prevent opportunities for direct contact with the skin or eyes and to prevent inhalation.
BeiLi is a professional manufacturer of MBN 3-methoxybenzonitrile CAS 1527-89-5 in China. We can provide costomers with "one-stop"packaging service,from research,development,production,export and so on.
1. Higest quality and good package
2. Fast delivery
3. Better payment term
4. Fast response to customer within 6 hours
5. Good business credit in UK, Netherlands, Germany, Norway, Italy, US, Japan, Korea,India, Thailand etc.